Source: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. Unidades: FCFRP, FMRP
Subjects: AUTOIMUNIDADE, CÉLULAS VEGETAIS, TRANSPLANTE DE ÓRGÃOS, BIOMARCADORES, DIABETES MELLITUS, TRANSPLANTE AUTÓLOGO, IMUNOSSUPRESSÃO
ABNT
COURI, Carlos Eduardo Barra e FARIAS, Kelen Cristina Ribeiro Malmegrim de e RODRIGUES, Maria Carolina de Oliveira. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement. Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Tradução . Lausanne: Frontiers Media, 2020. . Disponível em: https://doi.org/10.3389/978-2-88963-472-9. Acesso em: 06 out. 2024.APA
Couri, C. E. B., Farias, K. C. R. M. de, & Rodrigues, M. C. de O. (2020). New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement. In Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. Lausanne: Frontiers Media. doi:10.3389/978-2-88963-472-9NLM
Couri CEB, Farias KCRM de, Rodrigues MC de O. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2024 out. 06 ] Available from: https://doi.org/10.3389/978-2-88963-472-9Vancouver
Couri CEB, Farias KCRM de, Rodrigues MC de O. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2024 out. 06 ] Available from: https://doi.org/10.3389/978-2-88963-472-9